AUPH Free Cash Flow Growth
Aurinia Pharmaceuticals Inc · Free Cash Flow Growth
AUPH Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported87.80%period ending
AUPH TTM Free Cash Flow YoY % (-368.92% → 87.80%)
Year-over-year change
High-resolution chart · PNG
AUPH free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 87.7967% | |
| 158.6708% | |
| 204.5125% | |
| 323.5319% | |
| 5,195.2619% | |
| 410.9513% | |
| 229.1529% | |
| 174.3069% | |
| 95.5005% | |
| 68.4193% | |
| 57.2143% | |
| 67.1914% | |
| 71.4278% | |
| 56.9527% | |
| 49.8925% | |
| 12.2843% | |
| -13.2105% | |
| -38.7013% | |
| -106.1991% | |
| -27.7633% | |
| -50.7086% | |
| -49.0157% | |
| -21.4708% | |
| -99.6531% | |
| -60.873% | |
| -45.1875% | |
| -23.0492% | |
| -5.5882% | |
| -10.9416% | |
| -9.9723% | |
| -25.4673% | |
| -42.9249% | |
| -54.2099% | |
| -97.4393% | |
| -119.842% | |
| -78.1491% | |
| -47.8522% | |
| -22.3334% | |
| -5.2401% | |
| -18.1668% | |
| -34.0479% | |
| -21.197% | |
| -4.7661% | |
| -1.4446% | |
| -11.6002% | |
| -60.3867% | |
| -267.7139% | |
| -447.3939% | |
| -440.4159% | |
| -101.2895% | |
| 28.5563% | |
| 58.0276% | |
| 64.6785% | |
| 17.4551% | |
| -152.7429% | |
| -98.4704% | |
| -199.6882% | |
| -78.5388% | |
| 42.1342% | |
| 3.8224% | |
| 54.8242% | |
| 53.4346% | |
| 58.6166% | |
| 65.5273% | |
| 52.2124% | |
| 35.5304% | |
| 39.7053% | |
| 53.1459% | |
| 63.7808% | |
| 66.8321% | |
| 39.5543% | |
| 20.2211% | |
| -26.3325% | |
| -51.5843% | |
| -31.7967% | |
| -27.4102% | |
| -17.0718% | |
| -0.3002% | |
| -1.3274% | |
| 5.0435% | |
| 21.6064% | |
| 12.2412% | |
| -4.4704% | |
| -57.6572% | |
| -99.5155% | |
| -283.6446% | |
| -184.2757% | |
| -36.5097% | |
| -237.9056% | |
| -10.2027% | |
| -35.0809% | |
| -1,894.3189% | |
| 37.2117% | |
| 36.6682% | |
| 93.0792% | |
| 34.744% | |
| -14.013% | |
| -67.0784% | |
| -188.8654% | |
| -212.8373% |